Related Experiment Videos
[Enzyme substitution in Gauscher disease]
J Steensberg1, K G Nielsen, N J Brandt
1H:S Rigshospitalet, Juliane Marie Centret, afsnit for klinisk genetik 4062.
Ugeskrift for Laeger
|July 10, 1998
Summary
Gaucher's disease, a common inherited disorder, causes enlarged organs and bone pain. Enzyme replacement therapy using alglucerase has significantly improved patient outcomes and treatment strategies.
Area of Science:
- Biochemistry
- Genetics
- Internal Medicine
Background:
- Gaucher's disease is the most common inherited lysosomal storage disorder.
- Characteristic clinical manifestations include hepato-splenomegaly, thrombocytopenia, anemia, and bone pain.
Purpose of the Study:
- To discuss general treatment approaches for Gaucher's disease.
- To highlight current trends in enzyme substitution therapy.
Main Methods:
- Review of existing literature on Gaucher's disease treatment.
- Analysis of enzyme substitution therapy using alglucerase.
Main Results:
- Alglucerase enzyme substitution has revolutionized Gaucher's disease treatment.
- Significant improvements in patient prognosis have been observed.
Conclusions:
- Enzyme substitution therapy is a cornerstone in managing Gaucher's disease.
- Ongoing research and therapeutic advancements continue to enhance patient care.